Dr Michael Winlo spoke to WestBusiness’s Danielle LeMessurier about Emyria’s exciting work, including the growing impact of real-world data on drug development and our ongoing mission to find solutions to unsolved medical problems.

“We see a role for our service to be much broader than medicinal cannabis eventually. Any drug that’s shown to be safe but for where the benefits are still unclear — that’s the perfect role for this kind of set up,” he said.

Read the article here (behind paywall): Emyria flags expanding data system beyond medicinal cannabis treatments to repurpose other drugs | The West Australian